Alnylam, Tekmira Resolve All Litigation; Alnylam to Make $65M One-Time Payment

Alnylam

and Tekmira Pharma

announced a settlement agreement that resolves all litigation between the companies, and has signed a new licensing agreement that restructures the relationship and provides clarity on all intellectual property and licensing issues between the companies. As a result of the restructuring and new agreements, Tekmira will receive $65 million within 10 days and is eligible to receive $10 million in near-term milestone payments expected to be received in 2013.